Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07337590

Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Exero Medical Ltd. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Purpose: To evaluate the effect of xBar system utilization on clinical outcomes during recovery following colorectal surgery.

Detailed description

The study is intended to evaluate the effect of xBar utilization on clinical outcomes during recovery from colorectal surgery. During the study, patients in the intervention group admitted for low anterior resection surgery will have xBar placed during their index surgery. The overall morbidity, healthcare utilization costs, and stoma utilization of the intervention group will be compared to those of the historical control group, consisting of patients meeting the same inclusion/exclusion criteria of the patients in the intervention group. The xBar system, classified as a non-significant risk device in the pivotal study, is designed as an integrated platform for post-operative monitoring, built to fit into the existing clinical workflow without altering the standard surgical protocol.

Conditions

Interventions

TypeNameDescription
DEVICExBar™ SystemDevice: The xBar™ device functions by integrating a sensing electrode array into a standard surgical drain, thereby enabling monitoring without altering standard surgical protocols Description: The Exero Medical xBar™ System is designed to provide continuous postoperative monitoring of gastrointestinal (GI) anastomoses to support the early identification of anastomotic leaks. The device functions by integrating a sensing electrode array into a standard surgical drain, thereby enabling monitoring without altering standard surgical protocols.

Timeline

Start date
2026-03-10
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2026-01-13
Last updated
2026-04-15

Locations

4 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07337590. Inclusion in this directory is not an endorsement.